S100B and clostridium difficile infection: Under inflammatory conditions, including CDI, EGCs can also contribute to the inflammatory response by releasing S100B, a pro-inflammatory mediator and marker of reactive gliosis, when is released in high levels to the extracellular environment (5, 15).